Financials
- Market Capitalization 13.14 M
- Employee 24
- Founded 2003
- CEO Philip A. Serlin
- Website www.biolinerx.com
- Headquarter Israel
- FIGI BBG001Y26LK0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4729 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.94 USD | +4.00% | +8.14% | +1829.03% | +891.16% | 14.62 M USD | ||
| 4741 | PASG Passage Bio, Inc. - Common Stock | 4.32 USD | -3.14% | -13.25% | -24.08% | -51.13% | 13.86 M USD | ||
| 4751 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.84 USD | -1.63% | 0.00% | +32.24% | +1366.67% | 13.08 M USD | ||
| 4752 | COCP Cocrystal Pharma, Inc. - Common Stock | 0.96 USD | 0.00% | -5.88% | -3.03% | -44.19% | 13.24 M USD |